RxDoctor Payments Data

Clinical Cytogenetics: industry payments

Drug and device makers reported $17,776 in payments to providers registered in this specialty across Open Payments program years 20192025.

Providers
15
Received a payment
15 (100.0%)
Total reported
$18K
Average, those paid
$1,185

The average is computed only over providers who received something, because including the 0 who received nothing would produce a number that describes neither group. Totals are dominated by a small number of large royalty and consulting arrangements; the typical payment in this specialty is far smaller than the average implies.

What Medicare pays clinical cytogenetics clinicians

Part B allowed per clinician, 2024
$19,674
Of which, services
$19,674
Clinicians billing Part B
1

Across 1 clinical cytogenetics clinicians who billed Original Medicare Part B in 2024, Medicare allowed $19,674 in total — an average of $19,674 each, of which $19,674 was for services and the rest for drugs administered in the office.

This is not a salary. The rest is what Medicare allowed for services these clinicians billed — Original Medicare fee-for-service only. It excludes Medicare Advantage, which now covers more than half of Medicare enrollees, along with Medicaid and every commercial insurer, so for most clinicians it is a fraction of their practice. It is also gross revenue: staff, rent, supplies and malpractice premiums all come out of it before anyone is paid. Anyone quoting a figure like this as physician pay is misreading it.

By state

StateProvidersTotal reportedPer provider
Mississippi1$4,471$4,471
Georgia1$3,612$3,612
Arizona1$3,335$3,335
Massachusetts1$2,550$2,550
Colorado1$2,029$2,029
California5$1,449$290
Maryland1$119$119
Texas2$116$58
New York1$57$57
South Carolina1$39$39